Certican® (everolimus) in de novo heart transplantation

被引：0
|
作者：
Valantine, H
Zuckermann, A
Hummel, M
Lehmkuhl, H
Epailly, E
Fiane, A
Manito, N
Perrone, S
机构：
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2005年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 50 条
  • [41] A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus
    Hill, James A.
    Hummel, Manfred
    Starling, Randall C.
    Kobashigawa, Jon A.
    Perrone, Sergio V.
    Arizon, Jose M.
    Simonsen, Svein
    Abeywickrama, Kamal H.
    Bara, Christoph
    TRANSPLANTATION, 2007, 84 (11) : 1436 - 1442
  • [42] From clinical trials to clinical practice:: An overview of Certican® (Everolimus) in heart transplantation (vol 24, pg S185, 2005)
    Valantine, H
    Zuckermann, A
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (06): : 787 - 787
  • [43] Everolimus (Certican) after Heart Transplantation: 2 Years' Single Center Follow-Up in Calcineurin Inhibitor-Free Immunosuppression
    Engelen, M. A.
    Welp, H.
    Sindermann, J. R.
    Amler, S.
    Stypmann, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S23 - S23
  • [44] The Frequency of De Novo DSA in the Years Following Heart Transplantation
    Shen, A.
    Patel, J.
    Kittleson, M.
    Chang, D.
    Kransdorf, E.
    Geft, D.
    Nishihara, K.
    Czer, L.
    Esmailian, F.
    Kobashigawa, J. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 761 - 761
  • [45] De Novo Pulmonary Arterial Hypertension After Heart Transplantation
    Ahsan, Syed A.
    Berger, Joseph I.
    Lanier, Gregg
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S107 - S107
  • [46] EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Prokopenko, E. I.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2010, 12 (02): : 74 - 81
  • [47] Everolimus in complications of heart transplantation
    Eisen, HJ
    BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (6-7) : 408 - 409
  • [48] Everolimus (EVE) vs. Mycophenolate (MMF) De Novo After Heart Transplantation (HTx): Does It Matter for Long Term Outcomes?
    Masetti, M.
    Malossi, M.
    Potena, L.
    Prestinenzi, P.
    Manfredini, V.
    Barberini, F.
    Borgese, L.
    Sabatino, M.
    Magnani, G.
    Grigioni, E.
    Rapezzi, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S133 - S133
  • [49] EDEMA IN PATIENTS RECEIVING EVEROLIMUS "DE NOVO"
    Fernandez Rivera, Constantino
    Calvo Rodriguez, Maria
    Garcia Gago, Leticia
    Ferreiro Hermida, Tamara
    Bravo Gonzalez-Blas, Luis
    Lopez Muniz, Andres
    Alonso Hernandez, Angel
    TRANSPLANT INTERNATIONAL, 2019, 32 : 253 - 253
  • [50] Everolimus in Heart Transplantation: An Update
    Hirt, Stephan W.
    Bara, Christoph
    Barten, Markus J.
    Deuse, Tobias
    Doesch, Andreas O.
    Kaczmarek, Ingo
    Schulz, Uwe
    Stypmann, Joeg
    Haneya, Assad
    Lehmkuhl, Hans B.
    JOURNAL OF TRANSPLANTATION, 2013, 2013
12345